$35M sweet spot round size
Most of their 8 investments are in rounds between $12M and $40M
SURGE Therapeutics raised $32M on July 19, 2023
Investors: Bioluminescence Ventures, Piedmont Capital, 8VC, Alumni Ventures Group, Cancer Research Institute (CRI), Khosla Ventures, Pitango Venture Capital, Intuitive Ventures, KdT Ventures and Camford Capital
Lavita raised $5M on May 10, 2023
Investors: Camford Capital
Vevo Therapeutics raised $12M on December 8, 2022
Investors: General Catalyst, AIX Ventures and Camford Capital
SURGE Therapeutics raised $26M on October 17, 2022
Investors: Intuitive Ventures, Cancer Research Institute (CRI), 8VC, Khosla Ventures, Nirup Clinical Research, Pitango Venture Capital, Alumni Ventures Group and Camford Capital
Carbon Biosciences raised $38M on June 21, 2022
Investors: Astellas Venture Capital L.L.C., Longwood Fund, UTokyo Innovation Platform Co., Ltd., Solasta Ventures, Agent Capital and Camford Capital
Totus Medicines raised $40M on December 9, 2021
Investors: Northpond Ventures, DCVC Bio and Camford Capital
Strand Therapeutics raised $52M on June 23, 2021
Investors: Redmile Group, BeiGene, Playground Global, ANRI and Camford Capital
CG Oncology raised $47M on December 10, 2020
Investors: Perseverance Capital Management, ORI Capital Limited, Kissei Pharmaceutical Co Ltd and Camford Capital